Total Payments
$4,512
2024 Payments
$675.16
Companies
44
Transactions
265
Medicare Patients
8,349
Medicare Billing
$801,442
Payment Breakdown by Category
Food & Beverage$4,512 (100.0%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $4,512 | 265 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| GlaxoSmithKline, LLC. | $734.67 | 49 | $0 (2024) |
| Novo Nordisk Inc | $442.06 | 25 | $0 (2024) |
| Bayer Healthcare Pharmaceuticals Inc. | $397.06 | 19 | $0 (2024) |
| Amgen Inc. | $337.86 | 23 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $328.16 | 20 | $0 (2024) |
| Janssen Pharmaceuticals, Inc | $322.51 | 17 | $0 (2022) |
| Merck Sharp & Dohme LLC | $227.44 | 13 | $0 (2023) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $166.93 | 11 | $0 (2023) |
| Lilly USA, LLC | $149.46 | 10 | $0 (2024) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $134.51 | 9 | $0 (2023) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $675.16 | 36 | Amgen Inc. ($132.51) |
| 2023 | $616.79 | 35 | GlaxoSmithKline, LLC. ($200.64) |
| 2022 | $854.34 | 45 | Bayer HealthCare Pharmaceuticals Inc. ($201.91) |
| 2021 | $810.44 | 50 | Bayer HealthCare Pharmaceuticals Inc. ($146.55) |
| 2020 | $557.48 | 37 | GlaxoSmithKline, LLC. ($190.12) |
| 2019 | $523.18 | 30 | Janssen Pharmaceuticals, Inc ($83.65) |
| 2018 | $340.45 | 23 | Novo Nordisk Inc ($84.45) |
| 2017 | $134.50 | 9 | AstraZeneca Pharmaceuticals LP ($54.84) |
All Payment Transactions
265 individual payment records from CMS Open Payments — Page 1 of 11
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/12/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $21.48 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 12/11/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $18.15 | General |
| Category: Inflammation | ||||||
| 12/04/2024 | Insmed, Inc. | Arikayce (Drug) | Food and Beverage | In-kind items and services | $87.78 | General |
| Category: Respiratory | ||||||
| 11/26/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $21.94 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 11/21/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $14.56 | General |
| Category: Diabetes | ||||||
| 11/12/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $20.97 | General |
| Category: Biological | ||||||
| 11/06/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.59 | General |
| Category: Inflammation | ||||||
| 10/31/2024 | Novo Nordisk Inc | Wegovy (Drug) | Food and Beverage | In-kind items and services | $15.17 | General |
| Category: Obesity | ||||||
| 10/30/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.16 | General |
| Category: RESPIRATORY | ||||||
| 10/14/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $22.34 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 10/02/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.21 | General |
| Category: Inflammation | ||||||
| 09/11/2024 | GlaxoSmithKline, LLC. | AREXVY (Drug), TRELEGY ELLIPTA | Food and Beverage | In-kind items and services | $15.15 | General |
| Category: RESPIRATORY | ||||||
| 08/12/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $24.90 | General |
| Category: Oncology | ||||||
| 08/05/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.19 | General |
| Category: Inflammation | ||||||
| 07/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug) | Food and Beverage | In-kind items and services | $13.17 | General |
| Category: RESPIRATORY | ||||||
| 06/27/2024 | Amgen Inc. | Repatha (Biological) | Food and Beverage | In-kind items and services | $16.08 | General |
| Category: Cardiology | ||||||
| 06/12/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $7.82 | General |
| Category: Inflammation | ||||||
| 06/06/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $21.69 | General |
| Category: Diabetes | ||||||
| 05/30/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $16.30 | General |
| Category: Inflammation | ||||||
| 05/23/2024 | Esperion Therapeutics, Inc. | NEXLETOL (Drug) | Food and Beverage | In-kind items and services | $18.25 | General |
| Category: ANTILIPEMIC AGENTS | ||||||
| 05/23/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $15.28 | General |
| Category: RESPIRATORY | ||||||
| 05/08/2024 | Dexcom, Inc. | Dexcom G6 Transmitter (Medical Supply) | Food and Beverage | In-kind items and services | $25.00 | General |
| Category: Endocrinology | ||||||
| 04/19/2024 | Bayer Healthcare Pharmaceuticals Inc. | Kerendia (Drug) | Food and Beverage | In-kind items and services | $24.44 | General |
| Category: Cardio-renal | ||||||
| 04/10/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $8.18 | General |
| Category: Inflammation | ||||||
| 03/14/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $20.50 | General |
| Category: Diabetes | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 21 | 1,239 | 3,406 | $273,690 | $120,455 |
| 2022 | 22 | 1,116 | 3,163 | $290,150 | $135,047 |
| 2021 | 50 | 2,605 | 6,630 | $603,345 | $243,479 |
| 2020 | 40 | 3,389 | 8,172 | $826,744 | $302,461 |
Total Patients
8,349
Total Services
21,371
Medicare Billing
$801,442
Procedure Codes
133
All Medicare Procedures & Services
133 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2023 | 102 | 877 | $87,700 | $41,548 | 47.4% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 189 | 334 | $58,450 | $31,080 | 53.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 244 | 377 | $54,725 | $22,761 | 41.6% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 45 | 45 | $7,200 | $5,876 | 81.6% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Office | 2023 | 49 | 49 | $8,335 | $3,437 | 41.2% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2023 | 13 | 83 | $8,300 | $3,209 | 38.7% |
| 99454 | Remote monitoring of physiologic parameters, initial supply of devices with daily recordings or programmed alerts transmission, each 30 days | Office | 2023 | 12 | 63 | $8,190 | $2,479 | 30.3% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 54 | 58 | $5,400 | $2,008 | 37.2% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2023 | 16 | 16 | $4,400 | $2,000 | 45.5% |
| 96372 | Injection of drug or substance under skin or into muscle | Office | 2023 | 128 | 182 | $7,105 | $1,752 | 24.7% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 46 | 93 | $3,780 | $1,482 | 39.2% |
| G0180 | Physician or allowed practitioner certification for medicare-covered home health services under a home health plan of care (patient not present), including contacts with home health agency and review of reports of patient status required by physicians and | Office | 2023 | 22 | 28 | $2,100 | $968.53 | 46.1% |
| 93000 | Routine electrocardiogram (ecg) using at least 12 leads with interpretation and report | Office | 2023 | 38 | 39 | $2,626 | $421.56 | 16.1% |
| 87880 | Detection test by immunoassay with direct visual observation for streptococcus, group a (strep) | Office | 2023 | 19 | 20 | $615.00 | $324.00 | 52.7% |
| 71046 | X-ray of chest, 2 views | Office | 2023 | 18 | 18 | $1,415 | $262.04 | 18.5% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 29 | 29 | $1,248 | $220.69 | 17.7% |
| 81002 | Urinalysis, manual test | Office | 2023 | 49 | 58 | $1,380 | $197.78 | 14.3% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 20 | 20 | $420.00 | $168.00 | 40.0% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 14 | 14 | $688.00 | $144.90 | 21.1% |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | Office | 2023 | 96 | 858 | $7,491 | $70.31 | 0.9% |
| J0696 | Injection, ceftriaxone sodium, per 250 mg | Office | 2023 | 36 | 145 | $2,122 | $45.89 | 2.2% |
| 99490 | Chronic care management services, first 20 minutes of clinical staff time directed by health care professional, per calendar month | Office | 2022 | 126 | 1,001 | $100,100 | $47,718 | 47.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 249 | 453 | $65,230 | $30,784 | 47.2% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 144 | 265 | $46,242 | $25,225 | 54.5% |
| 99457 | Management using the results of remote vital sign monitoring per calendar month, first 20 minutes | Office | 2022 | 19 | 134 | $13,400 | $5,179 | 38.7% |
About Dr. Kamran Khan, MD
Dr. Kamran Khan, MD is a Internal Medicine healthcare provider based in Baytown, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/17/2006. The National Provider Identifier (NPI) number assigned to this provider is 1053339416.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kamran Khan, MD has received a total of $4,512 in payments from pharmaceutical and medical device companies, with $675.16 received in 2024. These payments were reported across 265 transactions from 44 companies. The most common payment nature is "Food and Beverage" ($4,512).
As a Medicare-enrolled provider, Khan has provided services to 8,349 Medicare beneficiaries, totaling 21,371 services with total Medicare billing of $801,442. Data is available for 4 years (2020–2023), covering 133 distinct procedure/service records.
Ad
Practice Information
- Specialty Internal Medicine
- Location Baytown, TX
- Active Since 07/17/2006
- Last Updated 07/21/2022
- Taxonomy Code 207R00000X
- Entity Type Individual
- NPI Number 1053339416
Products in Payments
- TRELEGY ELLIPTA (Drug) $469.18
- Kerendia (Drug) $397.06
- XARELTO (Drug) $277.64
- Otezla (Drug) $202.47
- FARXIGA (Drug) $198.73
- Rybelsus (Drug) $161.93
- Ozempic (Drug) $128.51
- ANORO ELLIPTA (Drug) $125.41
- AREXVY (Drug) $111.37
- JARDIANCE (Drug) $110.45
- Dayvigo (Drug) $90.55
- Arikayce (Drug) $87.78
- MOUNJARO (Drug) $83.16
- Repatha (Biological) $82.90
- DIFICID (Drug) $74.78
- RELISTOR (Drug) $68.06
- XIFAXAN (Drug) $66.45
- TRULICITY (Drug) $66.30
- Cologuard Collection Kit (Device) $59.38
- Tresiba (Drug) $56.57
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Internal Medicine Doctors in Baytown
Dr. Dinara Rose, M.d, M.D
Internal Medicine — Payments: $7,729
Internal Medicine $7,729
Dr. Luis Gonzalez, M.d, M.D
Internal Medicine — Payments: $6,904
Internal Medicine $6,904
Atif Qureshi, M.d, M.D
Internal Medicine — Payments: $6,870
Internal Medicine $6,870
Shehzad Sami, Md, MD
Internal Medicine — Payments: $5,864
Internal Medicine $5,864
Dr. Niravkumar Naik, M.d, M.D
Internal Medicine — Payments: $4,481
Internal Medicine $4,481
Shehpar Khan, M.d, M.D
Internal Medicine — Payments: $4,172
Internal Medicine $4,172